Human trial

SS-31

Also called elamipretide

Mitochondrial membranes, as a formal rare-disease programme. Confirm the current label before treating the approval point as settled.

A 15-second vertical explainer plays in this frame when the file is published.

What it is

SS-31, also called elamipretide, is a peptide studied for its interaction with the mitochondrial inner membrane. In this library it sits with a formal rare-disease programme, which is why it is not grouped with animal-only recovery peptides. Confirm the current label before treating any approval statement as settled.

Studied for

  • Mitochondrial inner-membrane function in a formal clinical programme.
  • A rare-disease use that has been discussed as approved. Check the label rather than repeating that point from memory.

The evidence

Human trial, in the narrow sense of a formal programme with human studies — not a general wellness result. It is rated here because the record is clinical development, and because the approval point should be checked rather than assumed.

What this page will not do

  • This is not a recovery, athletic, or longevity protocol.
  • Do not cite an approval unless you have looked at the current label.
  • We do not give doses.

Still open

  • What the current approved indication, if any, actually covers.
  • Which human outcomes were measured, and in how narrow a population.

Educational content only. This page does not diagnose, treat, cure, or prevent anything, and it is not a dose. Talk with a licensed physician before starting, stopping, or changing any medication. Library reviewed November 2026.